This finding is in consonance with late 1990s discoveries, in which it was shown that the expression of the RNA component of telomerase TERC, constitutively expressed in somatic cells, was upregulated early in tumour progression, whereas TERT expression was only activated in late stages,42 indicating that both genes might have a predictive value in the clinical setting. This evidence concerns the gene TERT and neoplasm.